Suppr超能文献

经腹腔或口服给予大鼠后的雪卡毒素 P-CTX-1 的毒代动力学。

Toxicokinetics of the ciguatoxin P-CTX-1 in rats after intraperitoneal or oral administration.

机构信息

Marine Biotoxins Program, Center for Coastal Environmental Health and Biomolecular Research, NOAA-National Ocean Service, 219 Fort Johnson Road, Charleston, SC 29412, USA.

出版信息

Toxicology. 2011 Jun 18;284(1-3):1-6. doi: 10.1016/j.tox.2011.02.005. Epub 2011 Feb 22.

Abstract

Ciguatoxins are voltage-gated selective algal toxins responsible for ciguatera fish poisoning. In this study we evaluate the toxicokinetics of one of the most common ciguatoxins found in the Pacific, the P-CTX-1, in rat after an oral or intraperitoneal (ip) dose of 0.26 μg/kg body weight. We report levels of ciguatoxin activity assessed over time in blood, urine and feces, and at 4 days in liver, muscle and brain, using the functional in vitro N2A cytotoxicity assay. Following exposure, the ciguatoxin activity exhibited a rapid systemic absorption that was followed by a bi-exponential decline, and data best fit a two-compartment model analysis. Maximum blood concentrations were reached at 1.97 and 0.43 h after the oral and ip dose, respectively. Ciguatoxin elimination from blood was slow with terminal half lives (t(½)β) estimated at 82 h for oral and 112 h for ip dosing. Ciguatoxin activity remained in liver, muscle and brain 96 h after ip and oral administration. While smaller amounts appeared in the urine, the main excretion route was feces, with peak rates reaching > 10 pg P-CTX-1 equivalents/h in both routes of administration. Assay guided fractionation showed the presence in the feces and liver of peaks of activity corresponding to the P-CTX-1 and to other less polar metabolites. In conclusion, biologically active ciguatoxins are detectable in blood, liver, muscle and brain, and continued to be excreted in urine and feces 4 days following exposure. Blood, as well as urine and feces may be useful matrices for low-invasive testing methods for ciguatera clinical cases.

摘要

雪卡毒素是一种电压门控选择性藻类毒素,可导致雪卡鱼中毒。在这项研究中,我们评估了一种在太平洋中最常见的雪卡毒素,即 P-CTX-1,在大鼠口服或腹腔内(ip)剂量为 0.26μg/kg 体重后的毒代动力学。我们报告了在血液、尿液和粪便中随时间评估的雪卡毒素活性水平,以及在肝、肌肉和脑中的水平,使用体外 N2A 细胞毒性测定法。暴露后,雪卡毒素活性迅速被全身吸收,随后呈双指数下降,数据最适合双室模型分析。口服和 ip 剂量后 1.97 和 0.43 h 分别达到最大血药浓度。雪卡毒素从血液中的消除缓慢,口服和 ip 给药的终末半衰期(t(½)β)分别估计为 82 h 和 112 h。口服和 ip 给药后 96 h,雪卡毒素活性仍存在于肝、肌肉和脑中。尽管尿液中的含量较少,但主要排泄途径是粪便,两种给药途径的峰值排泄率均达到>10 pg P-CTX-1 当量/h。基于测定的分级分离显示,粪便和肝中存在与 P-CTX-1 和其他极性较小的代谢物相对应的活性峰。总之,生物活性雪卡毒素可在血液、肝、肌肉和脑中检测到,并在暴露后 4 天继续在尿液和粪便中排泄。血液以及尿液和粪便可能是用于雪卡中毒临床病例的低侵入性测试方法的有用基质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验